Background Acute lymphocytic leukemia(ALL) is the most common malignant tumor in childhood. The traditional chemotherapy lacks of tumor specificity and the mortality rate related to chemotherapy is high. The insulin-like growth factor-I receptor(IGF-IR) are overexpressed in a variety of malignant tumor cells and participate in the occurrence and development of cancer.It can speculate that the childhood ALL cell line Jurkat may also overexpress IGF-IR and the monoclonal antibody(MAb) targeting IGF-IR could inhibit the growth of Jurkat cells. In this topic we will make some relative research.Objective To investigate the expression and cellular location of IGF-IR in Jurkat cell line.To explore the effects of IGF-IR MAb on the proliferation and apoptosis of Jurkat cell line.MethodJurkat cells was cultured in RPMI1640which contains10%fetal bovine serum(FBS).1. The expression of IGF-IR in Jurkat cells was detected by immunocytochemistry.2. Jurkat cells were incubated with various concentrations of IGF-IR MAb of0.001μg/ml,0.01μg/ml,0.1μg/ml,1μg/ml,10μg/ml for48hours. The effect of IGF-IR MAb on the proliferation of Jurkat cells was tested by CCK-8assay.3. According to the result of CCK-8,we chose the concentration of10μg/ml of IGF-IR MAb to treat with Jurkat cells.After48hours,the apoptosis rates of Jurkat cells were detected by flow cytometry(FCM).Result1. IGF-IR was generally expressed in Jurkat cell line and the positive expression rate of IGF-IR was100%.The IGF-IR was mainly expressed as a mixture of both cell membrane and cytoplasm staining. 2. The proliferation of Jurkat cells was inhibited after treated with different concentrations of IGF-IR MAb of0.001μg/ml,0.01μg/ml,0.1μg/ml, lug/ml,10μg/ml for48hours, and the inhibition rates were respectively (9.67±1.17)%,(14.89±1.06)%,(17.64±0.81)%,(20.15±1.14)%,(24.10±1.11)%. Along with the increasing concentration of the IGF-IR MAb, the proliferation inhibition rate of Jurkat cells also increased. Significant statistics difference was found in multiple comparison (P <0.05).3. After treated with IGF-IR MAb at the concentration of10μg/ml for48hours, the early apoptosis rate of Jurkat cells was (13.73±1.16)%, the late apoptosis rate of Jurkat cells was(20.44±2.47)%,the total apoptosis rate of Jurkat cells was (34.l8±3.41)%.In control group, the early apoptosis rate of Jurkat cells was (6.27±0.67)%, the late apoptosis rate of Jurkat cells was(10.18±0.81)%,the total apoptosis rate of Jurkat cells was (16.45±1.38)%. The early apoptosis rate, the late apoptosis rate and the total apoptosis rate were all higher than that in control group. Compared with the control group,the differences had statistical significance(P<0.05).Conclusion1. The IGF-IR was generally expressed in Jurkat cell line and the IGF-IR was mainly expressed as a mixture of both cell membrane and cytoplasm staining.2. IGF-IR MAb could inhibit the proliferation of Jurkat cells in a concentration-dependent manner.3. IGF-IR MAb could promote the apoptosis of Jurkat cells. |